ストックスクリーナーアプリを入手
57.97
0.31%
-0.18
前日終値:
$58.15
開ける：
$58.2
24時間の取引高:
958.36K
Relative Volume:
1.45
時価総額：
$3.17B
収益：
$1.28B
当期純損益:
$-222.15M
株価収益率:
-14.17
EPS:
-4.09
ネットキャッシュフロー:
$145.52M
1週間 パフォーマンス:
+2.84%
1か月 パフォーマンス:
+36.05%
6か月 パフォーマンス:
+41.84%
1年 パフォーマンス:
+23.31%
1日の値動き範囲:
$57.84
$58.42
1週間の範囲:
$55.50
$58.42
52週間の値動き範囲:
$32.48
$58.42
Livanova Plc Stock (LIVN) Company Profile
LIVN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
57.97 | 3.18B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
132.94 | 231.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.22 | 158.98B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
392.31 | 150.76B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.90 | 119.10B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.94 | 47.53B | 5.69B | 1.41B | 577.90M | 6.95 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
LivaNova PLC stock trend outlook and recovery pathInsider Selling & Community Consensus Trade Alerts - Newser
what moving averages say about livanova plcStock Surge & Safe Entry Momentum Tips - Newser
What institutional flow reveals about LivaNova PLC2025 Top Decliners & Technical Pattern Recognition Alerts - Newser
What are LivaNova PLC’s recent SEC filings showingQuarterly Growth Report & Step-by-Step Trade Execution Guides - خودرو بانک
Is LivaNova PLC a cyclical or defensive stockJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
LivaNova stock hits 52-week high at 57.52 USD By Investing.com - Investing.com Australia
Is LivaNova PLC a top pick in the sectorJuly 2025 Volume & Verified Stock Trade Ideas - خودرو بانک
What’s the RSI of LivaNova PLC stockMarket Performance Summary & Free Verified High Yield Trade Plans - خودرو بانک
Multi factor analysis applied to LivaNova PLCEarnings Recap Report & Low Drawdown Investment Ideas - Newser
LivaNova Appoints Donald Zurbay as a New Director - BioSpace
Using flow based indicators on LivaNova PLCEarnings Recap Summary & Capital Efficiency Focused Ideas - Newser
Published on: 2025-09-04 21:33:25 - beatles.ru
Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer - Yahoo Finance
LivaNova stock hits 52-week high at 57.52 USD - Investing.com
LivaNova PLC Appoints Donald Zurbay to Board of Director and Audit and Compliance Committee, Effective September 4, 2025 - MarketScreener
LivaNova Appoints Donald Zurbay to Board of Directors - TipRanks
LivaNova appoints Donald Zurbay to board of directors and audit committee - Investing.com
Don't Snooze on LivaNova's Sleep Apnea Device - Medical Device and Diagnostic industry
LivaNova appoints Don Zurbay to board of directors - Investing.com
LivaNova appoints Don Zurbay to board of directors By Investing.com - Investing.com UK
Medical Implants Market to Witness Remarkable Growth with Biotronik, Inc., Livanova Plc, NuVasive, Inc. - openPR.com
How sentiment analysis helps forecast LivaNova PLCMarket Trend Report & Reliable Intraday Trade Alerts - Newser
How cyclical is LivaNova PLC’s revenue streamJuly 2025 Retail & Reliable Entry Point Trade Alerts - خودرو بانک
Quantitative breakdown of LivaNova PLC recent moveWeekly Stock Summary & Community Consensus Stock Picks - Newser
Visual trend scoring systems applied to LivaNova PLCEarnings Risk Summary & Smart Investment Allocation Insights - Newser
Does LivaNova PLC fit your quant trading modelQuarterly Market Review & Verified Entry Point Signals - Newser
Exit strategy if you’re trapped in LivaNova PLCQuarterly Market Review & Weekly Return Optimization Plans - Newser
Analyzing LivaNova PLC with risk reward ratio chartsEarnings Growth Summary & Long-Term Safe Return Strategies - Newser
Applying big data sentiment scoring on LivaNova PLC2025 Top Gainers & Smart Investment Allocation Tips - Newser
Long term hold vs stop loss in LivaNova PLCJuly 2025 Drop Watch & Expert Curated Trade Setup Alerts - Newser
Can momentum traders help lift LivaNova PLCEarnings Growth Summary & Verified Momentum Watchlists - Newser
Custom watchlist performance reports with LivaNova PLCJuly 2025 PostEarnings & Real-Time Volume Trigger Notifications - Newser
Trend analysis for LivaNova PLC this weekPortfolio Return Report & Fast Momentum Stock Entry Tips - Newser
Tick level data insight on LivaNova PLC volatilityPortfolio Return Summary & Accurate Entry/Exit Alerts - Newser
Can LivaNova PLC rally from current levels2025 Volume Leaders & AI Forecasted Entry and Exit Points - Newser
Is LivaNova PLC trading at a discountSwing Trade & Technical Entry and Exit Alerts - خودرو بانک
LivaNova’s SWOT analysis: medical device maker’s stock faces growth hurdles - Investing.com
LivaNova's (NASDAQ:LIVN) investors will be pleased with their 25% return over the last five years - uk.finance.yahoo.com
LivaNova PLC stock volume spike explainedMarket Risk Summary & Reliable Intraday Trade Alerts - Newser
Live market analysis of LivaNova PLC2025 Key Lessons & Long-Term Capital Growth Strategies - Newser
LivaNova PLC At Critical Juncture — Bounce or BreakdownMarket Performance Summary & Growth Oriented Trading Recommendations - beatles.ru
Momentum divergence signals in LivaNova PLC chartWall Street Watch & Daily Oversold Bounce Ideas - Newser
What moving averages say about LivaNova PLCChart Signals & High Conviction Buy Zone Picks - Newser
Should value investors consider LivaNova PLCJobs Report & Verified Momentum Stock Alerts - 한국정경신문
The Bull Case for LivaNova (LIVN) Could Change Following Essenz Perfusion Launch in China—Learn Why - simplywall.st
Sentiment analysis tools applied to LivaNova PLCQuarterly Profit Report & AI Powered Market Trend Analysis - Newser
Bullish Candlestick Pattern Forms in LivaNova PLC getLinesFromResByArray error: size == 0 - kangso.co.kr
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
0.78%
0.31%
大文字化:
|
ボリューム (24 時間):